NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Biosect, BTW your logic is falling apart. If they are following ‘their plan’ then they are submitting to a journal with or without full FDA buy-in. Or are you suggesting that they haven’t even submitted yet or even by the late-breaker SNO deadline?

With the database now locked, the independent service firms managing the Clinical Trial are arranging for the independent statisticians to have access to the unblinded raw data from the Trial. Neither the Company nor any party other than the independent statisticians will have access to any unblinded data at this stage.

The statisticians will proceed as quickly as possible with analyses of the raw data and prepare summaries of the Trial results for review by the Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts, who will analyze the data with the statisticians in preparation for public announcement and scientific publication.

If that is the case they are misleading investors including you. Your suggested rationale is not part of their six step process and scientific presentation at congress is public announcement of results, of course a press release also always accompanies such presentation. LG stated that congress presention was part of the plan and that statement is congruent with the posted language. Also a year plus is not as quickly as possible to proceed with analysis of the data…

I am curious what the court of law and jury of peers opinion on that will be. They are approaching the destruction of any and all reasonable standards.